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ReviewNFAT Signaling: Choreographing
the Social Lives of Cells
target genes in a number of cell types. Rather an influx
of Ca2 through specialized Ca2 release activated Ca2
channels, or CRAC channels, is required (Figure 2). This
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Howard Hughes Medical Institute “inside-out” pathway was first recognized by Putney
Stanford University and colleagues, who found that depletion of intracellular
Stanford, California 94305 stores by activation of IP3-gated release from the endo-
2 Department of Molecular Biology plasmic reticulum resulted in the rapid influx of Ca2
University of Texas Southwestern Medical Center (Putney and Bird, 1993). Remarkably little is known of
Dallas, Texas 75390 the nature of the signals that pass from the ER to the
cell membrane, and several models are presently being
investigated. The requirement for inside-out signaling
Calcium signaling activates the phosphatase cal- for lymphocyte activation and NFAT translocation was
cineurin and induces movement of NFATc proteins first demonstrated in mutant lymphocytes selected us-
into the nucleus, where they cooperate with other pro- ing an NFAT-directed diptheria toxin construct (Serafini
teins to form complexes on DNA. Nuclear import is et al., 1995). Surviving cells were unable to activate
opposed by kinases such as GSK3, thereby rendering NFAT-dependent transcription and were also defective
transcription continuously responsive to receptor oc- in the activation of genes such as those encoding IL-2,
cupancy. Disruptions of the genes involved in NFAT IL-4, and CD40 ligand. The defect in the mutant cell lines
signaling are implicating this pathway as a regulator was shown to be a failure to promote an influx of Ca2
of developmental cell–cell interactions. through CRAC channels, resulting in only the rapid tran-
sient release of Ca2 from internal stores through IP3
General Features of NFAT Signaling receptors (Figure 2B). In these mutant cells, NFATc pro-
Probably no signaling molecule is so broad in its distri- teins do not stay in the nucleus but rather rapidly return
bution yet so specific in its functions as Ca2. Regulated to the cytoplasm. Nuclear localization of NFATc1over-
influx or release of Ca2 is critical to events as seemingly comes the defect in these cell lines, indicating that the
unrelated as fertilization, memory, and muscle contrac-
CRAC channel provides the persistent Ca2 signal nec-
tion. Indeed, if the reader remembers anything of this
essary to maintain NFATc proteins in the nucleus (Tim-
review, it is likely due to Ca2-dependent patterns of
merman et al., 1996). Similar defects in CRAC channel
transcription in specific neurons. This paradox of speci-
activation have been found in some patients with severeficity is a major question in modern biology and one that
combined immunodeficiency (SCID) (Feske et al., 2001;has eluded much effort (Berridge et al., 1998). One of
Le Deist et al., 1995). These individuals have normalthe roles of Ca2 is to regulate calcineurin (Klee et al.,
expression of the various signaling components used1998), which in turn dephosphorylates and induces the
by the antigen receptor but fail to activate genes suchnuclear localization of the cytoplasmic components
as IL-2, IL-4, and CD40 ligand that are cyclosporin A(NFATc proteins) of NFAT transcription complexes (Fig-
(CsA)-sensitive and largely dedicated to cellular interac-ure 1). In the nucleus, NFAT transcription complexes
tions. The importance of this channel is demonstratedassemble on DNA to activate genes primarily dedicated
by studies from Rao and colleagues, who showed thatto cell–cell interactions. Although this signaling pathway
it is essential for the activation of most TCR-dependentwas one of the first to be defined (Clipstone and
genes in T cells (Feske et al., 2001). Studies of thisCrabtree, 1992; Emmel et al., 1989; Flanagan et al., 1991;
inside-out signaling pathway have been hampered byLiu et al., 1991; Shaw et al., 1988), genetic redundancy
the inability to identify the gene(s) encoding the CRAChas made it difficult to study by conventional means. In
channel. Recently, the CaT1 gene was shown to haveaddition, homologs of NFATc family members are not
the expected electrophysiologic characteristics of thepresent in invertebrates. Thus, an understanding of the
CRAC channel (Yue et al., 2001). This channel has sevenfunctions of NFAT signaling has had to await the produc-
membrane spanning domains, four ankyrin repeats, andtion of mice containing null mutations in more than one
a domain similar to the Drosophila retinal Ca2 channelof the genes encoding its apparently redundant compo-
Trp and the C. elegans OSM-9 protein involved in olfac-nents. The molecular components shown in blue in Fig-
tion and mechanosensation. As yet it is not known ifure 1 constitute the core NFAT signaling cassette that
mutations of the CaT1 gene account for the CRAC chan-functions in many cell types in vertebrates.
nel defects in the SCID patients or the CRAC mutantSpecialized Ca2 Channels and “Inside-Out”
Jurkat cells. Nevertheless, the mechanism of CRACSignaling Are Necessary to Maintain NFATc
channel activation is one of the major unknown stepsProteins in the Nucleus
Ligand binding of many receptors results in the activa- in lymphocyte signaling.
tion of PLC, release of IP3, and a transient release of An additional example of the importance of special-
Ca2 from intracellular stores through IP3 receptors. This ized Ca2 channels in regulating NFATc function is seen
initial release of Ca2 is not sufficient to activate NFAT in perinatal hippocampal neurons where L-type chan-
nels activate NFATc4 translocation and function (Graef
et al., 1999). L-type channels are one of many different3 Correspondence: crabtree@cmgm.stanford.edu
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Figure 2. “Inside-Out” Signaling by the CRAC Channel is Essential
to Maintain NFATc Proteins in the Nucleus
The lower two panels show the short duration of the Ca2 fluxes in
CRAC mutants.
Figure 1. Multiple Levels of Control of NFAT Signaling the SP-repeats and the serine-rich region (Beals et al.,
(A) General features of NFAT signaling. The components shown in 1997a, 1997b; Zhu et al., 1998) (Figure 1B). Phosphoser-
blue appear to modulate NFAT signaling in many different cell types. ines within these regions appear to mask nuclear local-
Orange and green ovals represent FK506 and cyclosporin, respec- ization sequences (NLS). Dephosphorylation exposes
tively. Red arrows denote inhibitors and green arrows denote posi- the NLS and leads to rapid nuclear import. Surprisingly,
tive regulators of NFAT signaling. A simplified nuclear pore complex
the N-terminal Ca2/Cn-dependent translocation (CAT)(NPC) is shown; ATP hydrolysis is omitted for simplicity.
domain (Figure 1B) of NFATc1 was found not to be(B) Structural features of a typical NFATc protein. The domains
shown are from NFAT-C1, but the location of each domain appears structured in solution, suggesting that it requires a sec-
to be well conserved, except for the NES, which is shown for C1 ond protein to mask the NLS and the NES sequences
(Klemm et al., 1997). The CAT (Ca2/calcineurin-dependent translo- (Park et al., 2000). An alternative possibility is that the
cation) domain is shown for C1, but it is similar for all four NFATc N-terminal CAT domain makes contact with other re-
family members.
gions of the protein in the C terminus such as the
C-terminal NLS. Since NFATc proteins are involved in
several therapeutically important processes, structuraltypes of Ca2 channels in neurons, but the reason that
L-type channels are most effective at inducing translo- studies of the full-length phosphorylated and dephos-
pho-protein are likely to be critical for design of inhibitorscation of NFATc4 is not clear. NFATc4 appears to di-
rectly regulate the neuronal-specific IP3 receptor (IP3R1), of specific NFATc family members.
The recent observation that CnB mutant mice pheno-which is expressed during the first week of life. Since
IP3R1 is necessary for release of intracellular stores of copy NFATc3/c4 (c3/c4) mutant mice indicated that cal-
cineurin was somehow dedicated to NFAT signalingCa2, it is possible that L-type channels evoke a positive
feedback loop leading to nuclear translocation of (Graef et al., 2001a). The basis of this enzyme-substrate
specificity is likely related to a high affinity interactionNFATc4 and the activation of the IP3R1 gene with subse-
quent enhancement of Ca2 release. Such a positive between calcineurin complexes and NFATc proteins.
The N terminus of C1 is an effective dominant negativefeedback loop could be important in the refinement of
synaptic connections that occur during the critical pe- (Northrop et al., 1994), an action that arises from an
interaction between calcineurin and two conserved se-riod of mammalian neural development; however, this
speculation remains untested. quences within the N termini of NFATc proteins that
interact with calcineurin (Aramburu et al., 1999; Park etModulators of NFAT Import. The above studies called
attention to the fine balance between import and export al., 2000). Preexisiting Cn-NFATc complexes may ac-
count for the speed of dephosphorylation and transloca-of NFATc proteins. Several different regulators of NFATc
import and export have been reported (Figure 1). Nuclear tion of NFATc after a calcium stimulus, as well as the
specificity of calcineurin’s phosphatase activity onimport of NFATc proteins is controlled by the Ca2- and
calcineurin-dependent dephosphorylation of serines NFATc proteins. Indeed, transfected CnA will cotranslo-
cate with transfected NFATc3 (Zhu and McKeon, 1999);within the N terminus of the NFATc proteins located in
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however, it is not clear that the affinity between these Modulators and Mechanism of NFATc
Nuclear Exportproteins is high enough to induce cotranslocation of the
The realization that nuclear export (or prevention of im-endogenous proteins at physiologic concentrations.
port) of NFATc1 was critical to its Ca2 channel selectiv-To date, four cellular inhibitors of calcineurin phos-
ity lent interest to the mechanism of NFATc export. Iden-phatase complexes have been identified, all of which are
tification of kinases able to promote export came aboutable to block nuclear translocation of NFATc proteins.
by first identifying phosphoserines in the N terminus ofThese include the AKAP79 scoffold protein that binds
NFATc1 that were critical to nuclear export (Beals et al.,calcineurin and appears to prevent calcineurin’s access
1997a). Purification of the kinases necessary to phos-to substrates (Klauck et al., 1996). Interestingly, AKAP
phorylate these sites, but not other nonfunctional sites,also binds protein kinase A, which is an NFAT kinase
gave GSK3 (Figure 1) (Beals et al., 1997b). An NES wasthat opposes NFATc1 nuclear localization. A second
identified in NFATc1 that is essential for export, leadingcalcineurin inhibitor is the CAIN or CABIN protein, which
to the view that export was controlled by the exposuredirectly blocks calcineurin activity (Lai et al., 1998; Sun
of the NES, possibly by release from DNA (Klemm et al.,et al., 1998). A third inhibitor is the calcineurin B homo-
1997; Neal and Clipstone, 2001), a speculation that willlog, CHP, which is thought to bind to CnA but is not
require structural studies for verification. Recently,able to induce its activation (Lin et al., 1999). Finally, the
GSK3 has been shown to be a negative regulator ofDown Syndrome Critical Region 1 gene has provided an
lymphocyte activation and myocardial hypertrophy inintriguing connection with Down’s syndrome (Fuentes et
mice, as expected for an NFATc export kinase (Antosal., 1995; Rothermel et al., 2000). There are three DSCR1-
et al., 2002; Haq et al., 2000; Ohteki et al., 2000).related genes that are also called MCIP1, 2, and 3. Only
Other kinases that oppose NFATc translocation haveone of them is located at the Down’s syndrome critical
been suggested by a candidate gene approach and in-region, but they all apparently have the ability to block
clude p38, MAP kinase, and MEKK-1. These proteinsNFATc phosphorylation and translocation. Their role in
will phosphorylate NFATc1 or c3 in vitro. In many cellthe pathogenesis of Down’s syndrome is only specula-
types, Ras and MAP kinase signals facilitate NFAT-tive at this time.
dependent transcription rather than blocking it, as wouldPharmacologic inhibitors of NFATc translocation in-
be expected if these kinases opposed NFATc transloca-clude FK506 and CsA. These agents revolutionized
tion in vivo. In addition, casein kinase 1 has been purifiedtransplant therapy because of their ability to prevent the
using an immobilized c3 column and will phosphorylateimmune response to transplanted tissue. These chemi-
c3 in vitro (Zhu et al., 1998).cally different microbial products bind to two different
Coincidence Detection and Signal Integrationintracellular proteins, FKBP and Cyclophilin. The drug–
by NFAT Transcription Complexesprotein composite surface then binds to the interface of
NFATc proteins probably do not bind DNA in vivo with-the calcineurin A/B complex, blocking its phosphatase
out assistance, since a Ca2 signal by itself activatesactivity by preventing substrate access (Griffith et al.,
few target genes. This observation indicates that NFATc1995; Kissinger et al., 1995) (Figure 1). Although a num-
genes are probably not “master” genes that wear cam-ber of CsA targets other than calcineurin have been
ouflage clothes and live in caves, but rather that theyimplicated from biochemical studies, new results indi-
function within the community of proteins in a cell whencate that these inhibitors are remarkably specific for
a Ca2 signal is given. This observation was the basiscalcineurin and, in fact, NFATc proteins (Graef et al.,
of the reconstitution experiments used to define the2001a). This conclusion derives from the observation
components of NFAT complexes (Flanagan et al., 1991).that the phenotype of CnB mutant mice is nearly identi-
The structural basis of cooperative binding is rooted incal to that of NFATc3/c4 double mutant mice, which in
the contact residues between NFATc and DNA (Wolfeturn is identical to that seen in embryos of mothers given
et al., 1997). These structural and biochemical data indi-
CsA during early embryonic development. These studies
cate that NFAT transcription complexes function as sig-
establish the specificity of CsA for calcineurin in mice
nal integrators and concidence detectors. One signal
and indicate that at least in the E10.5 mouse, calcineurin must be Ca2/calcineurin (Crabtree, 1989), while the sec-
is largely dedicated to the control of NFATc proteins. ond can be developmental, as with the GATA4 and MEF2
These studies indicate that the drugs CsA and FK506 transcription factors in muscle cells (see below) or via
can be used for rapid and reversible inactivation of cal- the Ras-MAP kinase pathway in lymphocytes (Woodrow
cineurin in embryos. et al., 1993). Ras/MAP kinase signaling activates AP-1
A number of viruses mitigate immune responses by and perhaps other nuclear partners that cooperate with
inhibiting calcineurin/NFAT signaling. Most notable is NFATc1 and c2 to bind to DNA (Chen et al., 1998; Zhou et
the A238L protein of the African swine fever virus (Miskin al., 1998). Recent evidence indicates that certain NFAT
et al., 1998). This protein binds directly to calcineurin complexes might include transcriptional repressors.
and inhibits NFATc translocation in much the same way Feedback Control NFAT Signaling
as CsA and FK506. The repeated targeting of calcineurin Recently, several levels of feedback regulation over
by microorganisms as distinct as Trichoderma, Strepto- NFAT signaling have become evident. In muscle cells,
myces, and leukemia viruses indicates that calcineurin the calcineurin inhibitor DSCR1/MCIP-1 is activated by
is likely to be the “Achilles heel” in the immune response. calcineurin and NFATc (Yang et al., 2000), creating nega-
Supporting evidence for this view comes from data indi- tive feedback control (Figure 3). Positive feedback con-
cating that clinical immunosuppression of transplant re- trol is exerted in at least two ways. The NFATc1 gene
jection is achieved with only 50% inhibition of cal- is activated by antigen receptor signaling in T cells, with
a requirement for calcineurin, NFATc1(Northrop et al.,cineurin phosphatase activity (Batiuk et al., 1995)
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Figure 3. Feedback Control of NFAT Sig-
naling
1994), and a NFAT site within the NFATc1 promoter/ are surface bound and hence regulate only adjacent
cells. The four genes encoding the cytoplasmic subunitsenhancer (Zhou et al., 2002). This positive feedback loop
could reinforce the cellular commitment to lymphocyte of NFAT transcription complexes play critical roles in
regulating the genes necessary for interactions withactivation (Figure 3B) and may have a role in focusing
NFATc1 expression to endocardial precursors of heart cells that do not have antigen receptors. By this means,
NFAT signaling conveys the specificity of the T cell re-valves. A third level of positive feedback arises from
the observation that the IP3R1 gene, which is a critical ceptor to other cell types involved in the immune re-
sponse.component needed for NFAT activation, is a target of
calcineurin/NFAT signaling during the first week of life That NFAT signaling is at least partly dedicated to
cell–cell interactions is not surprising in light of the factin hippocampal and cortical neurons (Genazzani et al.,
1999; Graef et al., 1999). In neurons, positive feedback that the pathway was defined by a biochemical effort
to link the transcriptional activation of the IL-2 gene tomight have a role in synaptic refinement.
Lymphocyte Development and Activation the antigen receptor. The IL-2 gene was chosen as a
target of TCR signaling because it was critical to coordi-T lymphocyte activation initiates a highly choreo-
graphed series of gene regulations that, based on stud- nate the actions of other cells involved in an immune
response. IL-2’s regulatory regions turned out to beies of transcript arrays, activates or inactivates an esti-
mated 4000 genes, or about 15% of the mammalian small (Siebenlist et al., 1986) and, when analyzed, bound
NFAT transcription complexes at two sites and perhapsgenome (Diehn et al., 2002). Most of these genes are
not directly involved in the immune response but are at other critical sites (Shaw et al., 1988). Further analysis
indicated that this complex was made up of a heteroge-activated as a result of the transition from a metaboli-
cally inactive, nondividing cell to a highly metabolically nous cytoplasmic, Ca2- and CsA-sensitive subunit
(NFATc) and a nuclear subunit called NFATn (Emmel etactive, dividing cell. Perhaps the most interesting class
are genes dedicated to communication with other cell al., 1989; Flanagan et al., 1991). Calcineurin was found
to be necessary for the translocation of NFATc to thetypes (Figure 4). These include genes encoding proteins
such as TNF that are secreted and appear in the plasma nucleus and the function of NFAT transcription com-
plexes (Clipstone and Crabtree, 1992; Liu et al., 1991),and cytokines such as IL-2, 4, and others that produce
their effects by autocrine or paracrine mechanisms on thereby linking Ca2 influx induced by the antigen recep-
tor to the activation of the IL-2 gene (Figure 1).nearby cells. A final class of T cell activation genes
includes those such as CD40 ligand and Fas ligand that Targeted disruption of the genes involved in NFAT
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Figure 4. NFAT Signaling and Lymphocyte
Cell–Cell Interactions
signaling has demonstrated early roles in the develop- mice was examined in Rag1/ chimeric animals and
revealed a moderate reduction in the transition of CD4/ment and function of the cardiovascular, musculoskele-
ton, and nervous systems that have complicated analy- CD8 or double negative (DN) cells to double positive
(DP) CD4/CD8 cells and moderate reduction in thesis of immunologic phenotypes (Table 1). Although
calcineurin/NFAT signaling is almost certainly essential activation of several genes such as IL-2, IL-4, and others
(Ranger et al., 1998b; Yoshida et al., 1998). On the otherfor T and B cell development, this role has not been
directly demonstrated. Nevertheless, certain roles of hand, mice with null mutations in NFATc2 survive to
adulthood, and their lymphocytes show hyperprolifera-NFAT signaling are beginning to emerge. Because
NFATc1 is essential for morphogenesis of the mamma- tion in response to antigen receptor signals and eosin-
ophilic infiltration of the lungs, characteristic of severelian heart (see below), thymic development in C1 null
Table 1. Phenotypes of Mice with Mutations in NFAT Signaling Components
Other
Gene Names Null Phenotype Reference
CRAC Trp Failure of NFATc1 translocation and immune response (Le Deist et al., 1995; Feske
gene activation et al., 2001)
Connexin 45 Failure of NFATc1 translocation and cardiac (Kumai et al., 2000)
morphogenesis
CnA Moderate reduction in T cell activation (Zhang et al., 1996)
CnA Not yet reported
CnA Not available
CnB Vascular patterning abnormality (Graef et al., 2001a)
Memory defects in CaMK-Cre conditional deletion
CnB N.D.




NFATc1 c1, c Lethal failure of cardiac morphogenesis (de la Pompa et al., 1998;
Defects in thymic development and T cell activation Yoshida et al., 1998;
in Rag-1/ chimeras Ranger et al., 1998a)
NFATc2 c2, p Immune hyperactivation and allergic responses (Xanthoudakis et al., 1996;
Suppression of chrondrogenesis Ranger et al., 2000)
NFATc3 c3,4 Defects in thymic development and hyperproliferation (Oukka et al., 1998)
of lymphocytes
NFATc4 c4,3 Normal development, no apparent defects (Graef et al., 2001a)
c1  c2 Failure of T cell activation and immune response gene (Peng et al., 2001)
activation
c2  c3 Spontaneous TH1 differentiation, excessive allergic (Ranger et al., 1998c)
responses
c3  c4 Lethal vascular patterning defects (Graef et al., 2001a)
GSK3 Lethal defects in liver development (Ohteki et al., 2000; Antos et
Transgenic overexpression suppresses lymphocyte al., 2002; Hoeflich et al.,
development, activation, and cardiac hypertrophy 2000)
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allergic responses (Xanthoudakis et al., 1996). At least naling, an effect that appears to be in part mediated by
part of the hyperproliferative syndrome is likely to be NF-B and NFAT. Although NFATc and NF-B proteins
due to a failure to induce the Fas ligand, leading to the both bind to DNA through Rel domains, they do not
survival of cells that would normally undergo activation- share regulatory mechanisms. Nolan and colleagues
induced death. have recently shown that NFAT complexes contribute
Since NFATc1 and c2 have similar DNA binding speci- about 50% of the DNA binding activity found at the NF-
ficity (Ho et al., 1995), it was expected that NFATc1 and B binding sites in the HIV LTR (Kinoshita et al., 1997).
c2 would be redundant. This was confirmed when a Consistent with the binding data, both NFAT and NF-
double knockout was made by reconstituting Rag1/ B complexes make significant contributions to the rep-
mice with fetal liver from C1/C2 double knockout mice lication of the HIV virus in primary T cells (Kinoshita et
(Peng et al., 2001). Lymphocytes from C1/C2 null mice al., 1998).
made essentially no IL-2, IL-4, and TNF and reduced Calcineurin’s role in lymphocyte activation is under-
levels of IL-5. CD69, which is activated with only a stress scored by the success of CsA and FK506 as clinically
or Ras/PKC signal and is CsA insensitive and calcineurin effective immunosuppressants. However, mutation of
independent, was induced normally in these double the calcineurin A catalytic subunits produces minor
knockout cells, indicating that C1 and C2 are not in- T cell activation and developmental defects (Zhang et
volved in stress responses but are essential for activa- al., 1996), presumably due to redundancy with A and
tion of cytokine genes. perhaps the A chains. Mutation of the regulatory B
Mice with a mutation of the NFATc3 gene have defects subunit leads to death due to angiogenic patterning
in thymic development characterized by a loss of DP abnormalities at E10.5 (see below), and hence immune
cells through programmed cell death (Oukka et al., function can not be examined. Previous work has shown
1998). This loss of DP cells is likely related to the failure that CsA blocks positive selection as well as negative
to induce Bcl-2 during thymic development. No defects selection in the thymus and prevents lymphocyte activa-
in positive selection were noted and excessive activa- tion. CsA or FK506 completely prevents NFATc dephos-
tion of the Fas ligand in the periphery produced exces- phorylation and translocation to the nucleus, but does
sive activation-induced cell death. The possibility that not compromise the in vitro transcriptional activity of
the c3-deficient cells had compensated by control of NFAT complexes (Flanagan et al., 1991). Most of the
the DSCR1, CAIN, or other calcineurin/NFAT inhibitors effects of CsA are thought to be due to its ability to
(Figure 3) was not investigated. block nuclear translocation of NFATc proteins, since
Mice with mutations in both NFATc2 and c3 show nuclear expression of NFATc but not rel/NF-B proteins
spontaneous differentiation into TH2 (T helper 2) cells, or Fos-Jun family members renders Jurkat cells CsA
the highest levels of IgE yet recorded in mice, as well resistant (Timmerman et al., 1996).
as severe allergic responses (Ranger et al., 1998c).
T cells from these mice also show spontaneous hyper- Roles for Calcineurin-NFAT Signaling
proliferation and are independent of CD28 stimulation in Musculoskeletal Development
for activation. The paradox of hyperproliferation, en-
Calcineurin/NFAT signaling also regulates several as-
larged lymphoid tissue and excessive cytokine produc-
pects of skeletal muscle gene expression and remodel-
tion is likely related to defective activation of Fas ligand
ing (Figure 5). Calcineurin signaling has been implicated
and hence an inability to undergo activation-induced
in myoblast differentiation and in the mechanismcell death. This difference between the C3 and the C2
whereby insulin-like growth factor-1 induces myocyteC3 mouse may be in part related to the fact that C2 
hypertrophy based on the inhibition of these processesC3 mice have spontaneous nuclear accumulation of
by CsA. Ectopic expression of activated calcineurin alsoNFATc1, indicating that compensation for the lack of
stimulates differentiation and hypertrophy in culturedNFATc2 and c3 involves nuclear import of NFATc1 by
myocytes (Musaro et al., 1999; Semsarian et al., 1999),an as yet unknown mechanism.
whereas NFATc3 mutant mice exhibit skeletal muscleNFAT signaling in other cell types in the immune sys-
hypoplasia that apparently reflects impaired embryonictem appears to produce positive feedback regulation
muscle development (Kegley et al., 2001). The findingthat may be important for allergic responses (Figure 3C).
that hypertrophy of skeletal myocytes is accompaniedT cell activation leads to the induction of CD40L through
by nuclear translocation of NFATc1 and its associationNFAT signaling. One role of CD40 ligand in conjunction
with GATA2 suggests that elements of the pathway forwith B cell receptor signals and IL-4 is to activate NFAT
hypertrophic signaling are similar in cardiac and skeletalsignaling in B cells leading to immunoglobulin class
muscle cells (Molkentin et al., 1998; Musaro et al., 1999).switching and the production of IgE by some B cells
Calcineurin signaling has also been implicated in skele-(Verweij et al., 1990; Choi et al., 1994). IgE activates
tal muscle hypertrophy in vivo based on the ability ofNFATc1 translocation and function in mast cells, leading
CsA to prevent myofiber growth in response to chronicto the production of an array of cytokines and chemo-
load (Dunn et al., 1999). CsA also prevents muscle regen-kines that in turn influence T cell function (Figure 3C)
eration in response to injury (Abbott et al., 1998). The(Weiss and Brown, 2001). Signaling in eosinophils also
target genes of the calcineurin pathway that mediateuses NFAT transcription complexes to activate cyto-
these muscle-remodeling responses remain unknown.kines and cell surface molecules (Handen and Rosen-
Adult skeletal muscle fibers can be generally classi-berg, 1997). These observations imply that NFAT signal-
fied as fast or slow twitch, based on their contractile anding regulates the actions of cells needed for allergic
metabolic properties and associated gene expressionresponses.
HIV replication in T cells requires T cell receptor sig- profiles (Olson and Williams, 2000). These properties
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ated with the slow twitch phenotype. Treatment of ro-
dents with CsA induces a reduction in slow skeletal
muscle fibers and an increase in fast fibers, though this
transformation is incomplete (Chin et al., 1998; Serrano
et al., 2001). Conversely, expression of activated cal-
cineurin under control of a skeletal muscle-specific pro-
moter induces an increase in slow fibers and a decrease
in fast fibers in transgenic mice (Naya et al., 2000). How-
ever, in contrast to cardiac muscle, activated calcineurin
alone does not induce hypertrophy of skeletal myofibers
in vivo, suggesting that its hypertrophic effects in cul-
tured cardiomyocytes may require additional signaling
inputs.
A slow fiber-specific element of the slow troponin I
gene contains a canonical NFAT site that is required
for maximal expression in slow muscle fibers and for
maximal responsiveness to calcineurin (Calvo et al.,
1999; Wu et al., 2000). An adjacent binding site for the
MEF2 transcription factor cooperates with the NFAT site
to confer calcineurin sensitivity. Indeed, transgenic mice
that harbor a lacZ transgene linked to a multimerized
MEF2 site show slow fiber-specific expression of the
transgene, which can be inhibited by CsA or by muscle-
specific expression of exogenous MCIP1 (Wu et al.,
2001). These findings confirm results obtained in other
cell types in which calcineurin signaling has been shown
to stimulate the transcriptional activity of preexisting
MEF2 protein (Liu et al., 1997). The physical interaction
between NFAT and MEF2 proteins provides a mecha-
nism for linking calcineurin signaling to MEF2 activation
(Blaeser et al., 2000) (Figure 5).
An additional, potentially therapeutically significant
role of NFAT-dependent gene expression comes from
the observation that NFATc2 null mice show continued
growth of cartilage after it would normally undergo se-
nescence near puberty (Ranger et al., 2000). Remark-
ably, these null mice heal cartilaginous wounds more
effectively, indicating that NFATc2 signaling blocks car-
tilaginous differentiation. Mesenchymal stem cell lines
created from C2 null mice preferentially differentiate into
cartilage, while overexpression of C2 in these cells
blocked differentiation to cartilage, revealing a role in
the differentiation of mesenchymal stem cells into carti-
lage. As yet the ligand-receptor pair controlling C2 func-
tion in chrondrocytes has not been identified, but repre-
sents an important challenge for therapeutic advances
in this area. A straightforward approach would be to
Figure 5. NFAT Signaling in Cardiac and Skeletonal Muscle Devel- screen for ligands extracted from immature cartilage
opment and Function that could induce C2 dephosphorylation or translocation
(A) NFAT and MEF2 cooperate in muscle fiber type specification. in chrondrocytes.
(B) NFAT signaling in cardiac hypertrophy.
NFAT Signaling in the Development and Function
of the Cardiovascular Systemare largely dependent on the pattern of motor nerve
innervation and contractile activity. Slow twitch myofi- The Morphogenesis of the Heart and Cardiac
Valves—A Gap Junction-Dependentbers, which are involved in chronic contractile events,
exhibit an oxidative metabolism and maintain relatively Morphogenic Gradient?
Our moment-to-moment existence is dependent on thehigh intracellular calcium levels (100–300 nM). In con-
trast, fast twitch fibers, which are involved in rapid bursts delicate leaflets that allow effective pumping of blood
by the heart. Malformations of the heart and valves areof contraction, are glycolytic and are characterized by
brief, high amplitude calcium transients and lower cal- the most common congenital abnormality in humans
and occur in about 1 in 100 infants. Despite their remark-cium levels (50 nM).
Recent studies have revealed a key role for calcineurin able importance, relatively little is known about their
formation. Studies with mice deficient in calcineurin,signaling in activation of muscle-specific genes associ-
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response would be expected to be topographically
graded by virtue of the limited distribution of IP3 and
the anticipated morphologic result would be a ring-like
swelling similar to that of the endocardial cushions. Ad-
ditional work needs to be done to confirm this novel
mechanism for the formation of a morphogenic gradient.
However, delineation of the developmental steps in
heart valve formation will likely be critical to future thera-
peutic efforts to grow valves in situ by recapitulating
development. Since nearly 5% of the population of de-
veloping countries will eventually suffer valvular insuffi-
ciency, this is a worthwhile, if futuristic, goal.
Patterning of the Vasculature Requires NFAT
Signaling to Mediate Endothelial-
Figure 6. A Putative Gap Junction-Dependent Morphogenic Gradi- Mesenchymal Interactions
ent Essential for Heart Development Development of the vascular system produces a remark-
The model proposes a localized stimulus to an endothelial layer ably intricate and stereotyped pattern of vessels that
connected by gap junctions (blue), which then allows a graded distri- meet and probably anticipate the oxygenation needs of
bution of IP3 leading to a gradation of Ca2 and hence C1 activity. the organism. A critical aspect of vascular development
is the cross-talk that must occur between endothelial
cells and the surrounding embryonic mesenchyme thatconnexin 45, and NFATc1 have suggested that the for-
provides the cues needed for correct patterning (Yanco-mation of cardiac valves involves a gap junction-
poulos et al., 2000). Vascular patterning is more complexdependent morphogenic event, speculatively an intra-
than simply supplying oxygenation, since vessels mustcellular morphogeneic gradient (Figure 6).
take specific courses dictated by issues such as protec-At about embryonic day E8.5, NFATc1 is expressed
tion from injury and compatibility with movement. Micein a highly specific pattern only in endocardial cells that
bearing deletions in NFATc3 and c4 die at about E10.5are destined to make up the lining of the heart and valves
with vasculature patterning defects (Graef et al., 2001a).(de la Pompa et al., 1998; Ranger et al., 1998a). By the
c3/c4 null mice have no defect in the initial ability offollowing day, C1 is restricted to cells that will undergo
endothelial cells to differentiate, but rather these differ-an epithelial-to-mescenchymal transformation and make
entiated cells fail to respond to and give signals essentialup the endocardial cushion, which is the precursor to
for the assembly of vessels along specific pathways. Aboth the outflow valves and the septal structures. C1-
similar but more severe defect is observed in mice bear-deficient mice fail to form the valves in the outflow tract
ing a mutation of the CnB gene that prevents the Ca2-and fail to completely close the septum separating the
dependent interaction of CnB with CnA and the subse-two atria (de la Pompa et al., 1998; Ranger et al., 1998a).
quent dephosphorylation of NFATc4 (Graef et al.,
These defects are lethal by E13.5 due to cardiac failure.
2001a). Close inspection of these embryos revealed that
A graded distribution of C1 nuclear localization is seen
vessels often grew into inappropriate sites (the somites
in endothelial cells surrounding the presumptive site of
and neural tube) normally avoided by developing ves-
valve formation. When embryos are treated with CsA, it sels. Studies using transcript arrays identified several
prevents C1 nuclear localization and phenocopies the c3/c4 target genes including VEGF and other vascular
defect in valve development. Mice with mutations of growth factors. VEGF was found to be overexpressed
CnB also show failure of C1 nuclear localization in the about 3- to 4-fold higher in the somites, which are
endocardium (Graef et al., 2001a). Thus, calcineurin/ avoided by early vessels, indicating that NFAT signaling
NFAT signaling is necessary for valve formation, raising suppresses genes that would normally promote the
the question of the nature of the upstream regulator. growth of vessels. CsA administration to the mothers
This question was in part answered when valve abnor- reproduced the CnB mutant phenotype indicating that
malities similar to those in the C1 null mice were noted CsA was specific for calcineurin at this time of develop-
in connexin 45 null mice (Kumai et al., 2000). Remark- ment. Furthermore, since the phenotype of mice treated
ably, C1 was cytoplasmic in the endocardial cells of with CsA was similar to the c3/c4 null phenotype, CsA
knockout mice, indicating that connexin 45 was up- was selective for NFAT signaling at this time of develop-
stream of calcineurin and NFATc1. Connexins are com- ment (Graef et al., 2001a). By giving short pulses of drug,
plex molecular assemblies that form gap junctions con- calcineurin was shown to be essential between E7.5 and
necting one cell to its neighbors (Kelsell et al., 2001). E8.5. At this time, NFAT was found to be expressed and
Gap junctions allow transfer of certain ions, IP3, and localized to the nucleus in mesenchymal cells. Lower
electrical impulses from one cell to another. These ob- levels of c4 were seen in endothelial cells. The simplest
servations suggest a speculative model for the role of explanation of these results is that NFAT signaling sup-
connexin-45 in heart valve development shown in Figure presses expression of vascular attractants or activates
6. This model involves a localized inducing stimulus the expression of vascular inhibitors at or near sites
leading to PLC activation and the release of IP3. IP3 could where vessel growth must be limited.
then be transmitted though GAP junctions to adjacent An endothelial role for NFAT signaling in vascular de-
cells, leading to Ca2 release and the opening of extra- velopment and function was demonstrated by the stud-
cellular CRAC channels, influx of Ca2, activation of cal- ies of Redondo and colleagues who found that VEGF
activates NFATc translocation and transcription in en-cineurin, and nuclear import of C1. The transcriptional
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dothelial cells (Hernandez et al., 2001). CsA prevented of the ectopically expressed proteins remains to be re-
solved. The observation that about 2%–10% of NFATc3/NFAT-dependent transcription and endothelial migra-
tion as well as the activation of specific endothelial c4 double mutant mice live for a few weeks after birth
and appear to die of cardiac insufficiency (Graef et al.,genes such as Cyclooxygenase-2 (Cox-2). Blocking
NFAT translocation in adult animals with CsA prevented 2001a) indicates that c3 and c4 may play redundant
roles for cardiac development. It should also be pointedthe growth of vessels into tumors in the corneal micro-
pocket assay. These studies strongly indicate that while out that initial conclusions about the sufficiency of cal-
cineurin and NFATc4 to induce cardiac hypertrophythe role of mesenchymal NFAT signaling is to provide
angiogenic factors, the role of endothelial NFAT signal- were based on overexpression of constitutively active
proteins under control of the -myosin heavy chaining is to mediate the response to factors such as VEGF.
These studies have three important therapeutic implica- (MHC) promoter, which directs superphysiological lev-
els of expression.tions: (1) inhibitors of NFAT signaling might be effective
modulators of tumor angiogenesis, (2) the downstream Further evidence for the involvement of calcineurin-
NFAT signaling in cardiac hypertrophy has been pro-genes (secreted cytokines) induced by NFAT signaling
could be useful as inhibitors of tumor angiogenesis, vided by the observations that CsA and FK506 can pre-
vent myocyte hypertrophy in vitro and can block cardiacand (3) CsA’s beneficial effects on diseases such as
rheumatoid arthritis might be related to the NFATc regu- hypertrophy in vivo in response to numerous stimuli
including pressure overload (Shimoyama et al., 1999),lation of Cox-2 production by endothelial cells.
NFAT Signaling in Cardiac Growth and Function myocardial infarction (Deng et al., 2001), hypertension
(Sakata et al., 2000; Shimoyama et al., 2000), and someIn addition to its role in formation of the embryonic
cardiovascular system, the calcineurin-NFATc pathway (but not all) abnormalities in contractile proteins (Suss-
man et al., 1998). However, there has been considerableis required for function of the adult heart. Calcium is a
key regulator of cardiac contractility, growth, and gene variability in the responses of rodent models to cal-
cineurin-inhibitory drugs, with some studies reportingexpression. Remarkably, however, the first indication of
a specific role for calcineurin in the heart came from the complete rescue from hypertrophy and others reporting
partial or no effects (reviewed in Leinwand, 2001). It hasunexpected finding that NFATc4 associated with the
cardiac zinc finger transcription factor GATA4, which is also been reported that hypertrophy is exacerbated by
CsA treatment of mice harboring a mutation in theinvolved in cardiac development and hypertrophy (Mol-
kentin et al., 1998). -MHC gene that mimics a common mutation in humans
(Fatkin et al., 2000). Additional approaches will be re-The adult myocardium responds to a variety of stimuli
by a hypertrophic growth response, which is associated quired to resolve these discrepancies and to define the
specific pathologic stimuli that result in calcineurin acti-with an increase in size of cardiomyocytes, the assembly
of sarcomeres, and the activation of a fetal program of vation with resulting cardiac enlargement and heart
failure.cardiac gene expression. Cardiomyocyte hypertrophy
is triggered by a variety of calcium-dependent signaling Several genetic approaches involving overexpression
of calcineurin-inhibitory proteins in the heart or ablationpathways that are activated by extracellular agonists,
altered contractile activity, and volume or pressure over- of calcineurin genes have also provided strong support
for the involvement of calcineurin in cardiac hypertro-load on the heart (Frey et al., 2000a). Numerous fetal
cardiac genes that are induced during hypertrophy are phy, without the complications associated with second-
ary effects of CsA or FK506 on noncardiac tissues. Over-controlled by GATA4, but the mechanism that linked this
transcription factor to calcium signaling was unclear. expression of MCIP-1 (Figure 1) in the heart under
control of a cardiac-specific promoter severely inhibitsIn a two-hybrid screen, it was discovered that GATA4
interacted with NFATc4, providing a potential link be- hypertrophy in response to activated calcineurin, pres-
sure overload, and exercise (Rothermel et al., 2001).tween calcineurin signaling and the activation of fetal
cardiac genes during hypertrophy. This interaction is Intriguingly, MCIP-1 is upregulated in the heart in re-
sponse to activated calcineurin, which may provide anmediated by the second zinc finger of GATA4 and the
C-terminal portion of the Rel homology domain of endogenous feedback loop to suppress calcineurin sig-
naling. The upregulation of MCIP-1 expression in cardio-NFATc4 (Molkentin et al., 1998).
Subsequent studies showed that expression of con- myocytes is mediated by a cluster of 15 tandem NFAT
binding sites in the MCIP-1 gene promoter (Yang et al.,stitutively activate calcineurin in the hearts of transgenic
mice is sufficient to induce massive myocardial hyper- 2000).
Overexpression of Cabin/Cain and a dominant nega-trophy that progresses to dilated cardiomyopathy and
sudden death, mimicking the pathologic sequelae asso- tive calcineurin B subunit in the heart also prevents
hypertrophy in response to a variety of stimuli (De Windtciated with heart disease in humans. Evidence that NFAT
dephosphorylation is sufficient for hypertrophy has also et al., 2002; Zou et al., 2001). Recently, knockout mice
lacking the calcineurin A subunit gene were also shownbeen provided by the observation that an N-terminal
deletion mutant of NFATc4 that lacks the sites for cal- to be resistant to hypertrophy in response to pressure
overload (De Windt et al. 2002), adding further supportcineurin dephosphorylation, and is therefore constitu-
tively localized to the nucleus, can induce cardiac to the role of calcineurin in hypertrophy. Consistent with
the signaling pathway outlined in Figure 5B, cardiac-growth when overexpressed in vivo. However, the extent
of hypertrophy that results from overexpression of cal- specific expression of a constitutively active mutant of
GSK-3 in the heart substantially diminishes hypertrophycineurin is more severe than from activated NFATc4.
Whether this reflects the existence of calcineurin sub- in response to calcineurin activation and pressure over-
load, with reduced nuclear localization of NFAT (Antosstrates in addition to c4 or variations in expression levels
Cell
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et al., 2002). However, residual hypertrophy is still ob- ily members (Graef et al., 2001b). These observations
served in the presence of constitutively active GSK-3. raise the possibility that the NFATc family arose to suit
The basis for this resistance to GSK-3 signaling remains the specialized needs of vertebrates. The early results
to be resolved. from knockout animals indicate that this speculation is
Together, the weight of evidence argues strongly that likely to be correct. To date, NFAT signaling appears
calcineurin activation is critical for myocardial growth. necessary for the formation of a complex vascular sys-
The calcineurin-NFAT pathway therefore represents an tem, a recombinational immune system, certain aspects
auspicious target for therapy. However, it should also of the nervous system, and complex adaptive responses
be pointed out that the level of calcineurin expression characteristic of vertebrates.
in the heart is approximately 10-fold higher than in the A plausible mechanism for the origin of the NFATc
immune system, making it unlikely that CsA or FK506 gene family involves translocation of a Rel domain into
could be used chronically at sufficient doses to treat a precursor gene that contained a calcineurin-sensitive
cardiac disease without immune suppression and sec- Ca2 sensor, at once creating a new gene and destroying
ondary renal toxicity. An alternative approach would be the precursor. Gene duplication could then give rise to
to exploit various endogenous suppressors of the cal- the four existing NFATc genes (Graef et al., 2001b). This
cineurin-NFAT pathway to interfere with hypertrophic primitive translocation could provide, at the dawning of
signaling. vertebrate life, a new pathway linking Ca2 signals to
While dephosphorylated NFATc4 is able to induce the nucleus, useful for the formation of several new
hypertrophy when overexpressed in the heart, there is systems needed to deal with a larger body and complex
currently no evidence that hypertrophic growth requires adaptive responses. The evolutionary creation of a path-
the direct binding of NFATc4 to specific target genes way operating at the informationally rich interface of
that mediate the hypertrophic program. However, since Ca2and tyrosine kinase signaling, dedicated to cell–cell
GATA and MEF2 factors regulate numerous hypertro- interactions and structured to cooperate with the other
phic responsive genes, and since they both associate pathways existing 500 million years ago, could have
with NFATc4 (Molkentin et al., 1998; Blaeser et al., 2000) been helpful for making the transition to vertebrate life.
as well as each other, it is likely that combinatorial inter-
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